Results 151 to 160 of about 3,526 (188)

Modulation of L-Type Calcium Currents by Resveratrol-Induced Myogenesis in C2C12 Cells. [PDF]

Cells
Biagini A, Sallicandro L, Covarelli J, Gentile R, Mirarchi A, Farinelli A, Reali G, Del Bianco D, Quellari PT, Gliozheni E, Malvasi A, Baldini GM, Trojano G, Tubaro C, Bearzi C, Rizzi R, Arcuri C, Prontera P, Tinelli A, Fioretti B.   +19 more
europepmc   +1 more source

Analysis of effectiveness and safety of cisatracurium infusion during laparoscopic abdominal surgery. [PDF]

Front Surg
Hong Z, Lin X, Jin W.
europepmc   +1 more source

Rhabdomyolysis: a narrative review. [PDF]

Arq Neuropsiquiatr
Tengan CH, Oliveira ASB, Carvalho AAS, Souza CDS, Sobreira CFDR, Zanoteli E, Silva HCAD.   +6 more
europepmc   +1 more source

Interactions between Org9426 and other non-depolarizing neuromuscular blocking agents in rats in vivo

, 1993
openaire   +1 more source

Depolarizing Neuromuscular Blocking Agents

, 2017
Succinylcholine was first introduced into clinical practice in the 1950s, and is currently the only depolarizing neuromuscular blocker in use. It is unique among the drugs used for muscle relaxation in its rapid onset and short duration of action. These characteristics account for its extensive use in scenarios requiring emergency control of the airway.
Caroline S. Gross, Zhiling Xiong
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Increased Sensitivity to Depolarizing and Nondepolarizing Neuromuscular Blocking Agents in Young Rat Hemidiaphragms

Anesthesiology, 2001
Background Newborn neuromuscular junctions are more sensitive to d-tubocurarine than more mature preparations. It is unclear whether the same modifications occur with newer nondepolarizing agents and depolarizing agent succinylcholine.
Richard Robitaille, F Donati, Donati François   +2 more
exaly   +3 more sources

Interactions between ORG9426 and other non-depolarizing neuromuscular blocking agents in ratsin vivo

Journal of Anesthesia, 1992
In this study, combined neuromuscular blocking effects of ORG9426 with other non-depolarizing neuromuscular blocking agents were investigated. About 20% steady state neuromuscular block was established by a continuous infusion of one of 6 neuromuscular blocking agents (ORG9426, vecuronium, pancuronium, pipecuronium, d-tubocurarine and metocurine). Then
Kazuhiko Watanabe
exaly   +3 more sources

A study in vitro of new short-acting, non-depolarizing neuromuscular blocking agents

Biochemical Pharmacology, 1969
Abstract Presently available short-acting, depolarizing myoneural blocking agents have significant side effects such as increased intraocular tension, cardiac arrhythmias desensitization of the postjunctional membrane, skeletal muscle injury and muscle pains. Non-depolarizing blocking drugs do not produce profound blocks of short duration.
Richard J Kitz, S Ginsburg
exaly   +3 more sources

Interactions of Volatile Anesthetics with Non-Depolarizing Neuromuscular Blocking Agents

, 1995
Drug interactions involving neuromuscular blocking agents are divided into two classes: one is interaction between neuromuscular blocking drugs and other classes of drug.The second is interactions with neuromuscular blocking agents each other.
Kazuaki Fukushima
openaire   +2 more sources

DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND INTRAOCULAR PRESSURE IN VIVO

Anesthesiology, 1957
J B Dillon, D B Taylor, Dillon John B
exaly   +3 more sources